Home > News > Promise of Revolutionising European Drug Discovery Markets
May 30th, 2006
Promise of Revolutionising European Drug Discovery Markets
Abstract:
The advent of nanotechnology-based products such as nano-arrays and dendrimers is anticipated to revolutionise treatments for diseases such as cancer. The realisation that the nano-scale has certain properties needed to solve important medical challenges and cater to unmet medical needs is driving nano-medical research. Increasingly, research is focusing on the novel chemical and physical properties of nano-sized materials to develop new applications that improve human health. Frost & Sullivan finds that the Drug Discovery Nanotechnology Market in Europe earned revenues of US$174.2 million in 2005 and estimates this to reach US$545.4 million in 2012.
Source:
prnewswire
Bookmark:
| Related News Press |
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||